Aurinia Pharmaceuticals
AUPH
#4753
Rank
S$2.44 B
Marketcap
S$18.39
Share price
-2.26%
Change (1 day)
65.18%
Change (1 year)

Aurinia Pharmaceuticals (AUPH) - Total debt

Total debt on the balance sheet as of December 2025 : S$96.39 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's total debt is S$96.39 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Aurinia Pharmaceuticals - Total debt on balance sheet (from 1999 to 2025)

Total debt by year

Year Total debt Change
2025-12-31S$96.05 M-10.97%
2024-12-31S$0.10 B-16.31%
2023-12-31S$0.12 B1088.9%
2022-12-31S$10.84 M-8.22%
2021-12-31S$11.81 M6.23%
2020-12-31S$11.12 M
2019-12-31N/A
2013-12-31N/A-100%
2012-12-31S$0.04 M-56.93%
2011-12-31S$0.1 M
2008-12-31S$18.42 M1758.8%
2007-12-31S$0.99 M-72.32%
2006-12-31S$3.57 M-45.77%
2005-12-31S$6.6 M-16.95%
2004-12-31S$7.94 M1000.84%
2003-12-31S$0.72 M60.14%
2002-12-31S$0.45 M90.03%
2001-12-31S$0.23 M
2000-11-30S$0.18 M-18.33%
1999-11-30S$0.22 M-46.84%
1998-11-30S$0.42 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Regeneron Pharmaceuticals
REGN
S$3.48 B 3,516.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
S$15.83 M-83.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
S$2.17 M-97.75%๐Ÿ‡บ๐Ÿ‡ธ USA